ABEO Abeona Therapeutics Inc.
$4.31▲ +0.00%
Healthcare
Other
Volume 38.5K
Avg Volume (10D) 1.09M
Key Metrics & Fundamentals
Market Cap
$246.46M
P/E Ratio
6.7
Div Yield
0.00%
52W Range
4.00 - 7.65
% vs 50 MA
-19.72%
% vs 200 MA
-21.73%
RSI-14
31.6
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.49
Free Cash Flow
-$17.98M
Gross Rev
$11.38M
Gross Profit
$7.20M
EBITDA
-$11.47M
COGS
$4.18M
Operating Exp
$20.86M
Operating Income
-$13.65M
EBIT
-$13.65M
Pretax Income
-$20.19M
Net Income
-$20.19M
EPS (Diluted)
-0.35
Price & Volume History
Loading chart…
Recent News
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 2, 2026 7:30 AM ET
Abeona Therapeutics Highlights ZEVASKYN Launch Momentum, Revenue Growth at H.C. Wainwright
MarketBeat · Sep 22, 2026 6:02 PM ET
Abeona Expands ZEVASKYN Network as RDEB Launch Gains Momentum
MarketBeat · Sep 22, 2026 4:02 AM ET
Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of FAYUVI™ Gene Therapy for Sanfilippo Syndrome Type A (MPS IIIA)
GlobeNewswire · Sep 18, 2026 7:30 AM ET
ABEO Stock Gains On Approval For A Drug Abeona Sold, Rating For The One It Sells
Stocktwits · Sep 17, 2026 7:33 PM ET
Sector Update: Healthcare Stocks Edge Higher Pre-Bell Wednesday
MT Newswires · Sep 16, 2026 9:17 AM ET
Abeona Therapeutics Activates 8th ZEVASKYN Treatment Center in Florida
MT Newswires · Sep 16, 2026 8:04 AM ET
Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN®
GlobeNewswire · Sep 16, 2026 7:30 AM ET
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 7:30 AM ET
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 1, 2026 7:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ABEO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.